Should patients on vitamin K antagonists be treated differently?

@article{Pokorney2015ShouldPO,
  title={Should patients on vitamin K antagonists be treated differently?},
  author={Sean D. Pokorney and Christopher B. Granger},
  journal={European heart journal},
  year={2015},
  volume={36 23},
  pages={1431-3}
}
Relative to warfarin, non-vitamin K oral anticoagulants (NOACs) are at least as good at preventing stroke or systemic embolism, cause less haemorrhagic stroke, and result in modestly lower mortality. Thus, the European Society of Cardiology has recommended NOACs in place of vitamin K antagonists (VKAs) in most patients with atrial fibrillation (class IIa, level of evidence A). According to one report, the use of NOACs in the USA has increased to . 60% of prescriptions for patients being… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
3 Citations
13 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Similar Papers

Loading similar papers…